Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

NCT03341871 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03341871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03341871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 27, 2017
Completion date
September 15, 2020
Enrollment
1,095 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus (hcv)